141 related articles for article (PubMed ID: 26198415)
1. Dual Drug Delivery Using Lactic Acid Conjugated SLN for Effective Management of Neurocysticercosis.
Devi R; Jain A; Hurkat P; Jain SK
Pharm Res; 2015 Oct; 32(10):3137-48. PubMed ID: 26198415
[TBL] [Abstract][Full Text] [Related]
2. Targeted SLNs for management of HIV-1 associated dementia.
Rai A; Jain A; Jain A; Jain A; Pandey V; Chashoo G; Soni V; Sharma PR
Drug Dev Ind Pharm; 2015; 41(8):1321-7. PubMed ID: 25113430
[TBL] [Abstract][Full Text] [Related]
3. Histological assessment of follicular delivery of flutamide by solid lipid nanoparticles: potential tool for the treatment of androgenic alopecia.
Hamishehkar H; Ghanbarzadeh S; Sepehran S; Javadzadeh Y; Adib ZM; Kouhsoltani M
Drug Dev Ind Pharm; 2016; 42(6):846-53. PubMed ID: 26154267
[TBL] [Abstract][Full Text] [Related]
4. Aceclofenac-loaded chondroitin sulfate conjugated SLNs for effective management of osteoarthritis.
Bishnoi M; Jain A; Hurkat P; Jain SK
J Drug Target; 2014 Nov; 22(9):805-12. PubMed ID: 24955618
[TBL] [Abstract][Full Text] [Related]
5. Solid lipid nanoparticles for sustained pulmonary delivery of Yuxingcao essential oil: Preparation, characterization and in vivo evaluation.
Zhao Y; Chang YX; Hu X; Liu CY; Quan LH; Liao YH
Int J Pharm; 2017 Jan; 516(1-2):364-371. PubMed ID: 27884712
[TBL] [Abstract][Full Text] [Related]
6. Lipid nanoparticles of zaleplon for improved oral delivery by Box-Behnken design: optimization, in vitro and in vivo evaluation.
Dudhipala N; Janga KY
Drug Dev Ind Pharm; 2017 Jul; 43(7):1205-1214. PubMed ID: 28274147
[TBL] [Abstract][Full Text] [Related]
7. Long-term stability, biocompatibility and oral delivery potential of risperidone-loaded solid lipid nanoparticles.
Silva AC; Kumar A; Wild W; Ferreira D; Santos D; Forbes B
Int J Pharm; 2012 Oct; 436(1-2):798-805. PubMed ID: 22867992
[TBL] [Abstract][Full Text] [Related]
8. In vivo pharmacokinetics and biodistribution of resveratrol-loaded solid lipid nanoparticles for brain delivery.
Jose S; Anju SS; Cinu TA; Aleykutty NA; Thomas S; Souto EB
Int J Pharm; 2014 Oct; 474(1-2):6-13. PubMed ID: 25102112
[TBL] [Abstract][Full Text] [Related]
9. In vivo and cytotoxicity evaluation of repaglinide-loaded binary solid lipid nanoparticles after oral administration to rats.
Rawat MK; Jain A; Singh S
J Pharm Sci; 2011 Jun; 100(6):2406-17. PubMed ID: 21491451
[TBL] [Abstract][Full Text] [Related]
10. Brain targeted solid lipid nanoparticles for brain ischemia: preparation and in vitro characterization.
Morsi NM; Ghorab DM; Badie HA
Pharm Dev Technol; 2013; 18(3):736-44. PubMed ID: 23477526
[TBL] [Abstract][Full Text] [Related]
11. Folic acid functionalized long-circulating co-encapsulated docetaxel and curcumin solid lipid nanoparticles: In vitro evaluation, pharmacokinetic and biodistribution in rats.
Pawar H; Surapaneni SK; Tikoo K; Singh C; Burman R; Gill MS; Suresh S
Drug Deliv; 2016 May; 23(4):1453-68. PubMed ID: 26878325
[TBL] [Abstract][Full Text] [Related]
12. Sustained release of piroxicam from solid lipid nanoparticle as an effective anti-inflammatory therapeutics in vivo.
Peng LH; Wei W; Shan YH; Chong YS; Yu L; Gao JQ
Drug Dev Ind Pharm; 2017 Jan; 43(1):55-66. PubMed ID: 27498809
[TBL] [Abstract][Full Text] [Related]
13. Lactoferrin bioconjugated solid lipid nanoparticles: a new drug delivery system for potential brain targeting.
Singh I; Swami R; Pooja D; Jeengar MK; Khan W; Sistla R
J Drug Target; 2016; 24(3):212-23. PubMed ID: 26219519
[TBL] [Abstract][Full Text] [Related]
14. Physicochemical characterization techniques for solid lipid nanoparticles: principles and limitations.
Kathe N; Henriksen B; Chauhan H
Drug Dev Ind Pharm; 2014 Dec; 40(12):1565-75. PubMed ID: 24766553
[TBL] [Abstract][Full Text] [Related]
15. Targeting of AIDS related encephalopathy using phenylalanine anchored lipidic nanocarrier.
Vyas A; Jain A; Hurkat P; Jain A; Jain SK
Colloids Surf B Biointerfaces; 2015 Jul; 131():155-61. PubMed ID: 25988279
[TBL] [Abstract][Full Text] [Related]
16. Candesartan cilexetil loaded solid lipid nanoparticles for oral delivery: characterization, pharmacokinetic and pharmacodynamic evaluation.
Dudhipala N; Veerabrahma K
Drug Deliv; 2016; 23(2):395-404. PubMed ID: 24865287
[TBL] [Abstract][Full Text] [Related]
17. Histopathological evaluation of caffeine-loaded solid lipid nanoparticles in efficient treatment of cellulite.
Hamishehkar H; Shokri J; Fallahi S; Jahangiri A; Ghanbarzadeh S; Kouhsoltani M
Drug Dev Ind Pharm; 2015; 41(10):1640-6. PubMed ID: 25382163
[TBL] [Abstract][Full Text] [Related]
18. Adenosine conjugated lipidic nanoparticles for enhanced tumor targeting.
Swami R; Singh I; Jeengar MK; Naidu VG; Khan W; Sistla R
Int J Pharm; 2015; 486(1-2):287-96. PubMed ID: 25839415
[TBL] [Abstract][Full Text] [Related]
19. Intranasal delivery of nanoparticle encapsulated tarenflurbil: A potential brain targeting strategy for Alzheimer's disease.
Muntimadugu E; Dhommati R; Jain A; Challa VG; Shaheen M; Khan W
Eur J Pharm Sci; 2016 Sep; 92():224-34. PubMed ID: 27185298
[TBL] [Abstract][Full Text] [Related]
20. Physicochemical characterization by AFM, FT-IR and DSC and biological assays of a promising antileishmania delivery system loaded with a natural Brazilian product.
Marquele-Oliveira F; Torres EC; Barud Hda S; Zoccal KF; Faccioli LH; Hori JI; Berretta AA
J Pharm Biomed Anal; 2016 May; 123():195-204. PubMed ID: 26897464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]